Clarithromycin in adult-onset Still's disease: A study of 6 cases

Rheumatology International

Volumn 30, Issue 4, 2010, Pages 555-560

  Saviola, Gianantonio ^a   Benucci, Maurizio ^b   Abdi Ali, Lul ^a   Baiardi, Paola ^a   Manfredi, Mariangela ^b   Bucci, Mariarosaria ^c   Cirino, Giuseppe ^c  

^a IRCCS   (Italy)

^b Osp S Giovanni Di Dio   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Adult onset Still's disease; AOSD; Clarithromycin; Macrolide antibiotics; Rheumatic disease

Indexed keywords

CLARITHROMYCIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; HYDROXYCHLOROQUINE; INDOMETACIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; ANTIINFECTIVE AGENT;

ADULT; ADULT ONSET STILL DISEASE; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE DURATION; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LOW DRUG DOSE; MALE; NAUSEA; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; TASTE AVERSION; TREATMENT RESPONSE; CASE REPORT; DOSE RESPONSE; DRUG COMBINATION; PATHOLOGY; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHOTREXATE; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77949880385     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1277-9     Document Type: Article

References (20)

1. Efthimiou P, Paik PK, Bielory L (2006) Diagnosis and management of adult's onset Still's disease. Ann Rheum Dis 65:564-572
2. Fardet L, Coppo P, Kettaneh A, Dehoux M, Cabane J, Lambrotte O (2008) Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome. Arthritis Rheum 58:1521-1527 (Pubitemid 351705942)
3. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al (1992) Preliminary criteria for classiWcation of adult onset Still's disease. J Rheumatol 19:424-430
4. Fautrel B, Sibilia J, Mariette X, Combe B, The Club Rheumatismes et InXammation (2005) Tumor necrosis factor α blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 64:262-266
5. Marchesoni A, Ceravolo GP, Buttafarano N, Rossetti A, Tosi S, Fantini F (1997) Cyclosporin A in the treatment of adult onset Still's disease. J Rheumatol 24:1582-1587 (Pubitemid 27320702)
6. Fautrel B, Borget C, Rozenberg S, Meyer O, Le Loet X, Masson C et al (1999) Corticosteroid sparing eVect of low dose methotrexate treatment in adult Still's disease. J Rheumatol 26:373-378 (Pubitemid 29066742)
7. Vignes S, Wechsler B, Amoura Z, Papo T, Frances C, Huong DL et al (1998) Intravenous immunoglobulin in adult onset Still's disease refractory to non-steroidal anti-inXammatory drugs. Clin Exp Rheumatol 16:295-298 (Pubitemid 28219169)
8. Efthimiou P, Georgy S (2006) Pathogenesis and management of adult-onset Still's disease. Semin Arthritis Rheum 36:144-152 (Pubitemid 44691884)
9. Husni ME, Maier LA, Mease PJ et al (2002) Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum 46:1171-1176 (Pubitemid 34525822)
10. Kraetsch HG, Antoni C, Kalden JR et al (2001) Successful treatment of a small cohort of patients with adult onset of Still's disease with inXiximab: Wrst experiences. Ann Rheum Dis 60:55-57
11. Lequerré T, Quartier P, Roselini D et al (2008) Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemiconset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 67:302-308 (Pubitemid 351281262)
12. Saviola G, Abdi-Ali L, Shams-Eddin S, Davoli C, Taglietti M (2004) Clarithromycin in adult-onset Still's disease. Case report with 1 year follow-up. Clin Exp Rheumatol 22:379
13. Ianaro A, Ialenti A, MaYa P, Sautebin L, Rombolà I, Carnuccio R et al (2000) Anti inXammatory activity of macrolide antibiotics. J Pharmacol Exp Ther 292:156-163
14. Saviola G, Abdi-Ali L, Rossini P, Campostini L, Coppini A, Gori M et al (2002) Clarithromycin in rheumatoid arthritis patients not responsive to disease-modifying anti-rheumatic drugs: an open uncontrolled pilot study. Clin Exp Rheum 20:373-378
15. Ogrendik M (2007) Effects of clarithromycin in patients with active rheumatoid arthritis. Curr Med Res Opin 23:515-522 (Pubitemid 46456899)
16. Moskowitz R, Lesko M, Hooper M (2006) Open-label study of clarithromycin in patients with undiVerentiated connective tissue disease. Semin Arthritis Rheum 36:82-87
17. Saviola G, Benucci M, Cirino G (2007) Comments on: Effects of clarithromycin in patients with active rheumatoid arthritis. Curr Med Res Opin 23:515-522
18. Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG (2008) Clarithromycin targets neutrophilic airway inXammation in refractory asthma. Am J Respir Crit Care 177:148-155
19. Giamarellos-Bourboulis EJ (2008) Immunomodulatory therapies for sepsis: unexpected Effects with macrolides. Int J Antimicrob Agents 32(Suppl 1):S39-S43
20. Ivetic-Tkalcevic V, Bosniak B, Pasalic I, Hrvacic B, Situm K, Dominis Kramaric M et al (2008) The anti-inXammatory activity of clarithromycin inhibits TNF- production and prolongs survival following lipopolysaccharide administration in mice. Int J Antimicrob Antimicrob Agents 32:195-196